Tirzepatide is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss.
Specification: 5mg/ 10mg/ 15mg/ 20mg/ 30mg/ 60mg
CAS No.: 2023788-19-2
Formula: C225H348N48O68
Molar mass: 4813.527
Purity: >99%
Test Result |
Tests | Specifications | Results |
Appearance | White powder | Conforms |
Solubility | Freely soluble in water | Conforms |
MS (ESI) | 4813.45¡À1.0 | 4813.27 |
Purity(HPLC) | ¡Ý99.0% | 99.48% |
Peptide Content | ¡Ý85.0% | 94.97% |
Water Content (Karl Fischer) | ¡Ü10.0% | 2.02% |
Related Substance(HPLC) | Any individual impurity¡Ü0.7% | 0.18% |
PH(5.0MG/ML) | 6.0-8.0 | 7.57 |
High molecular protein | <5.0% | N.D |
Acetate Content | ¡Ü15.0% | N.D |
TFA Content | ¡Ü0.5% | N.D |
Sodium | ¡Ü5.0% | 1.48% |
Bacterial endotoxins | <10EU/mg | Conforms |
Microbial Limits | Total aerobic microbial count ¡Ü1000cfu/g Total yeast and mold count ¡Ü200cfu/g | Conforms Conforms |
Assay(HPLC) | 95.0~105.0%(on anhydrous and salt-free substance basis) | 103.66% |
Medical Use
Tirzepatide is indicated to improve blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise.
Tirzepatide is also indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management. It reduces food intake by lowering appetite and slowing down digestion in the stomach, helping reduce body weight.
Side Effects (higher likelihood the higher the dose)
nausea, vomiting, diarrhea, decreased appetite, constipation, upper abdominal discomfort, and abdominal pain
Contraindications
People with a personal or family history of
1. Medullary thyroid cancer
2. Multiple endocrine neoplasia syndrome type 2.
Trade Term
FOB
Shippment
Lead Time: 7-15 Days
Should there arise any issues with customs clearance, we are committed to resupplying the goods until such time as the customer get them.
Payment
Alipay, Paypal, Bitcoin, WesternUnion, T/T
